NCT00004189View on ClinicalTrials.gov

Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

July 31, 2003

Conditions

LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL

filgrastim

DRUG

becatecarin

DRUG

cisplatin

Trial Locations (3)

78229

Cancer Therapy and Research Center, San Antonio

St. Luke's Lutheran Hospital, San Antonio

78229-3900

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00004189 - Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter